ProQR Therapeutics (PRQR) Return on Assets (2014 - 2023)
ProQR Therapeutics recorded quarterly Return on Assets of 0.0% in Q4 2023, up 11.16% quarter-over-quarter from 0.0% in Q3 2023, and little changed year-over-year from 0.0% in Q4 2022.
ProQR Therapeutics' Return on Assets history runs 9 years deep, the most recent figure standing at 0.0% for Q4 2023.
- In Q4 2023, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2023 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Assets came in at 0.0% for Q4 2023 at ProQR Therapeutics, up from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2019 to a low of 0.01% in Q3 2019.
- A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
- Across the five-year window, Return on Assets retreated 1 bps in 2019 and increased 1 bps in 2021, its largest moves.
- ProQR Therapeutics' Return on Assets stood at 0.01% in 2019, then soared by 33 bps to 0.0% in 2020, then rose by 27 bps to 0.0% in 2021, then plunged by 61 bps to 0.0% in 2022, then surged by 51 bps to 0.0% in 2023.
- According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -0.01% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | -0.01% |
| Mar 31, 2020 | -0.01% |
| Dec 31, 2019 | -0.01% |
| Sep 30, 2019 | -0.01% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 0.01% |
| Mar 31, 2018 | 0.01% |
| Dec 31, 2016 | 0.00% |
| Mar 31, 2015 | 0.00% |
| Dec 31, 2014 | 0.00% |